GlassScriptPhysician profile
Roberto Jose Diaz
NPI 1649591595
$37,106.98
in general payments reported to CMS, 2019-2025
50 companies · $1,406 in 2025
The $1,406 reported for 2025 was more than what 75% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $3,595 · 2021: $4,710 · 2022: $4,596 · 2023: $1,326 · 2024: $2,216 · 2025: $1,406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,470 · Travel and Lodging: $459 · Education: $19.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,469.72 |
| Travel and Lodging | $459.00 |
| Education | $19.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $21,447.13 | 2019-2020 | |
| Medtronic, INC. | $7,648.04 | 2021-2025 | Synchromedii, Inceptiv |
| Abbott Laboratories | $1,397.08 | 2020-2025 | Proclaim, Eterna, Ionicrf |
| Boston Scientific Corporation | $843.96 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, Superion Indirect Decompression System |
| Abbvie INC. | $553.32 | 2021-2025 | Botox |
| Globus Medical, INC. | $552.95 | 2025 | Excelsius Gps, Xlif, Senza |
| Collegium Pharmaceutical, INC. | $468.77 | 2019-2025 | Belbuca, Xtampza, Nucynta |
| Biotissue Holdings INC. | $424.85 | 2023-2025 | |
| Allergan, INC. | $361.66 | 2019-2022 | |
| Nevro Corp. | $323.81 | 2021-2024 | Senza |
| Almatica Pharma LLC | $290.47 | 2021-2023 | Gralise |
| Genentech USA, INC. | $284.64 | 2019-2024 | Vabysmo |
| Saluda Medical Americas, INC. | $240.85 | 2024-2025 | Evoke |
| Tersera Therapeutics LLC | $192.14 | 2019-2023 | Prialt |
| Si-Bone, INC. | $189.81 | 2019-2024 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Diaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.